Cervical cancer screening continues to limit provision of contraception

Eleanor Schwarz, Mona Saint, Ginny Gildengorin, Tracy A. Weitz, Felicia H. Stewart, George F. Sawaya

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: Balancing needs for contraception and cervical cancer screening is challenging for clinicians. We assessed US obstetrician/gynecologists' practices regarding requirement of Pap testing before prescribing oral contraceptive or emergency contraceptive pills. Methods: Questionnaires structured as clinical vignettes describing women desiring contraception with different risks of cervical dysplasia were mailed to a national sample of 355 obstetrician/gynecologists. Results: A minority (3%) of the 185 obstetrician/gynecologists who responded would refill 12 months of oral contraceptives without requiring Pap testing. However, most would provide a limited supply of oral contraceptives until Pap testing could be performed. A substantial proportion (11-16%) would refuse to prescribe emergency contraception to women who they felt required Pap testing. Younger physicians, those practicing in academic settings and those who follow American Cancer Society guidelines were more willing to prescribe contraceptives without Pap testing. Conclusions: Cervical cancer screening continues to limit prescription of routine and emergency contraception by many US obstetrician/gynecologists.

Original languageEnglish (US)
Pages (from-to)179-181
Number of pages3
JournalContraception
Volume72
Issue number3
DOIs
StatePublished - Sep 1 2005

Fingerprint

Oral Contraceptives
Contraception
Early Detection of Cancer
Uterine Cervical Neoplasms
Postcoital Contraception
Postcoital Contraceptives
Uterine Cervical Dysplasia
Contraceptive Agents
Prescriptions
Guidelines
Physicians

Keywords

  • Cervical cancer screening
  • Contraception
  • Emergency contraception
  • Pap testing

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Schwarz, E., Saint, M., Gildengorin, G., Weitz, T. A., Stewart, F. H., & Sawaya, G. F. (2005). Cervical cancer screening continues to limit provision of contraception. Contraception, 72(3), 179-181. https://doi.org/10.1016/j.contraception.2005.04.009

Cervical cancer screening continues to limit provision of contraception. / Schwarz, Eleanor; Saint, Mona; Gildengorin, Ginny; Weitz, Tracy A.; Stewart, Felicia H.; Sawaya, George F.

In: Contraception, Vol. 72, No. 3, 01.09.2005, p. 179-181.

Research output: Contribution to journalArticle

Schwarz, E, Saint, M, Gildengorin, G, Weitz, TA, Stewart, FH & Sawaya, GF 2005, 'Cervical cancer screening continues to limit provision of contraception', Contraception, vol. 72, no. 3, pp. 179-181. https://doi.org/10.1016/j.contraception.2005.04.009
Schwarz, Eleanor ; Saint, Mona ; Gildengorin, Ginny ; Weitz, Tracy A. ; Stewart, Felicia H. ; Sawaya, George F. / Cervical cancer screening continues to limit provision of contraception. In: Contraception. 2005 ; Vol. 72, No. 3. pp. 179-181.
@article{a148ae3dbc7c4648a5d3b97e474cac30,
title = "Cervical cancer screening continues to limit provision of contraception",
abstract = "Purpose: Balancing needs for contraception and cervical cancer screening is challenging for clinicians. We assessed US obstetrician/gynecologists' practices regarding requirement of Pap testing before prescribing oral contraceptive or emergency contraceptive pills. Methods: Questionnaires structured as clinical vignettes describing women desiring contraception with different risks of cervical dysplasia were mailed to a national sample of 355 obstetrician/gynecologists. Results: A minority (3{\%}) of the 185 obstetrician/gynecologists who responded would refill 12 months of oral contraceptives without requiring Pap testing. However, most would provide a limited supply of oral contraceptives until Pap testing could be performed. A substantial proportion (11-16{\%}) would refuse to prescribe emergency contraception to women who they felt required Pap testing. Younger physicians, those practicing in academic settings and those who follow American Cancer Society guidelines were more willing to prescribe contraceptives without Pap testing. Conclusions: Cervical cancer screening continues to limit prescription of routine and emergency contraception by many US obstetrician/gynecologists.",
keywords = "Cervical cancer screening, Contraception, Emergency contraception, Pap testing",
author = "Eleanor Schwarz and Mona Saint and Ginny Gildengorin and Weitz, {Tracy A.} and Stewart, {Felicia H.} and Sawaya, {George F.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1016/j.contraception.2005.04.009",
language = "English (US)",
volume = "72",
pages = "179--181",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Cervical cancer screening continues to limit provision of contraception

AU - Schwarz, Eleanor

AU - Saint, Mona

AU - Gildengorin, Ginny

AU - Weitz, Tracy A.

AU - Stewart, Felicia H.

AU - Sawaya, George F.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Purpose: Balancing needs for contraception and cervical cancer screening is challenging for clinicians. We assessed US obstetrician/gynecologists' practices regarding requirement of Pap testing before prescribing oral contraceptive or emergency contraceptive pills. Methods: Questionnaires structured as clinical vignettes describing women desiring contraception with different risks of cervical dysplasia were mailed to a national sample of 355 obstetrician/gynecologists. Results: A minority (3%) of the 185 obstetrician/gynecologists who responded would refill 12 months of oral contraceptives without requiring Pap testing. However, most would provide a limited supply of oral contraceptives until Pap testing could be performed. A substantial proportion (11-16%) would refuse to prescribe emergency contraception to women who they felt required Pap testing. Younger physicians, those practicing in academic settings and those who follow American Cancer Society guidelines were more willing to prescribe contraceptives without Pap testing. Conclusions: Cervical cancer screening continues to limit prescription of routine and emergency contraception by many US obstetrician/gynecologists.

AB - Purpose: Balancing needs for contraception and cervical cancer screening is challenging for clinicians. We assessed US obstetrician/gynecologists' practices regarding requirement of Pap testing before prescribing oral contraceptive or emergency contraceptive pills. Methods: Questionnaires structured as clinical vignettes describing women desiring contraception with different risks of cervical dysplasia were mailed to a national sample of 355 obstetrician/gynecologists. Results: A minority (3%) of the 185 obstetrician/gynecologists who responded would refill 12 months of oral contraceptives without requiring Pap testing. However, most would provide a limited supply of oral contraceptives until Pap testing could be performed. A substantial proportion (11-16%) would refuse to prescribe emergency contraception to women who they felt required Pap testing. Younger physicians, those practicing in academic settings and those who follow American Cancer Society guidelines were more willing to prescribe contraceptives without Pap testing. Conclusions: Cervical cancer screening continues to limit prescription of routine and emergency contraception by many US obstetrician/gynecologists.

KW - Cervical cancer screening

KW - Contraception

KW - Emergency contraception

KW - Pap testing

UR - http://www.scopus.com/inward/record.url?scp=23644444167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23644444167&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2005.04.009

DO - 10.1016/j.contraception.2005.04.009

M3 - Article

C2 - 16102551

AN - SCOPUS:23644444167

VL - 72

SP - 179

EP - 181

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 3

ER -